Enovis Corp
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Medical Devices
業務概覽 Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recoverysegment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
公司地址 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
電話號碼 +1 302 252-9160
傳真號碼 +1 800 936-6569
公司網頁 https://www.enovis.com
員工數量 7802
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Phillip Benjamin Berry Senior Vice President and Chief Financial Officer 美元 586.25K 26/02/2026
Ms. Patricia A. Lang Senior Vice President and Chief Human Resources Officer 美元 492.50K 26/02/2026
Mr. Terry D. Ross Group President, Prevention and Recovery -- 26/02/2026
Mr. Damien McDonald Chief Executive Officer and Director -- 26/02/2026
Mr. John Kleckner Vice President, Controller and Chief Accounting Officer -- 26/02/2026
Mr. Bradley J. Tandy Senior Vice President and Chief Legal Officer 美元 492.50K 26/02/2026
Ms. Laura Singleton Vice President, Human Resources -- 15/12/2025
Mr. Louie Vogt Group President, Reconstructive -- 26/02/2026
Mr. Oliver Engert Chief Administrative Officer -- 26/02/2026
 
董事會成員
董事會 職務 更新日期
Ms. Angela S. Lalor Independent Director 26/02/2026
Ms. Sharon L. Wienbar Chairman of the Board 26/02/2026
Mr. Damien McDonald Chief Executive Officer and Director 26/02/2026
Mr. Philip A. Okala Independent Director 26/02/2026
Mr. Brady R. Shirley Director 26/02/2026
Ms. Barbara W. Bodem Independent Director 26/02/2026
Mr. Liam J. Kelly Independent Director 26/02/2026
Mr. Rajiv Vinnakota Independent Director 26/02/2026
Mr. A. Clayton Perfall Independent Director 26/02/2026
Dr. Christine Ortiz, B.S.,M.S.,PhD Independent Director 26/02/2026
 
所屬ETF (更新日期: 07/03/2026 03:48)
代號 名稱 佔比% ▼ 持有日期
IJHiShares Core S&P Mid-Cap ETF<0.000001%28/02/2026
IJJiShares S&P Mid-Cap 400 Value ETF<0.000001%27/02/2026
IUSViShares Core S&P US Value ETF<0.000001%27/02/2026
IWDiShares Russell 1000 Value ETF<0.000001%28/02/2026
IWRiShares Russell Mid-Cap ETF<0.000001%28/02/2026
IYHiShares US Healthcare ETF<0.000001%28/02/2026
IYYiShares Dow Jones US ETF<0.000001%28/02/2026
KATScharf ETF<0.000001%29/08/2025
LSEQHarbor Long-Short Equity ETF<0.000001%01/08/2025
MSLCMorgan Stanley Pathway Large Cap Eq ETF<0.000001%30/06/2025
ONEOStt Strt® SPDR® Russell 1000 Momt FocETF<0.000001%30/06/2025
PAMCPacer Lunt MidCap Multi-Factor Alt ETF<0.000001%26/02/2026
QVMSInvesco S&P SmallCp 600 QVM Mlt-fctr ETF<0.000001%23/06/2025
RALSProShares RAFI® Long/Short<0.000001%30/04/2022
RGTRoyce Global Trust, Inc.<0.000001%30/09/2025
RZVInvesco S&P SmallCap 600® Pure Value ETF<0.000001%22/12/2025
SMMDiShares Russell 2500 ETF<0.000001%27/02/2026
STXKStrive Small-Cap ETF<0.000001%11/09/2025
TMEDT. Rowe Price Health Care ETF<0.000001%04/11/2025
USVMVictoryShares US Sm Md Cp Val Momt ETF<0.000001%22/09/2025
  1    2    3    4   5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.